Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan

Steven D. Podos^*, Howard Trachtman, Gerald B. Appel, Andrew S. Bomback, Bradley P. Dixon, Jack F.M. Wetzels, H. Terence Cook, Samir V. Parikh, Matthew C. Pickering, James Tumlin, Craig B. Langman, Liz Lightstone, C. John Sperati, Erica Daina, Koenraad Peter Bouman, Kara Rice, Jane A. Thanassi, Mingjun Huang, Carla Nester, Giuseppe Remuzzi

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

1 results
- Title
- Start date(ascending)

Supplementary Material for: Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan
Podos, S. D. (Contributor), Trachtman, H. (Contributor), Appel, G. B. (Contributor), Bomback, A. S. (Contributor), Dixon, B. P. (Contributor), Wetzels, J. F. M. (Contributor), Cook, H. T. (Contributor), Parikh, S. V. (Contributor), Pickering, M. C. (Contributor), Tumlin, J. (Contributor), Langman, C. B. (Contributor), Lightstone, L. (Contributor), Sperati, C. J. (Contributor), Daina, E. (Contributor), Bouman, K. P. (Contributor), Rice, K. (Contributor), Thanassi, J. A. (Contributor), Huang, M. (Contributor), Nester, C. (Contributor) & Remuzzi, G. (Contributor), Karger Publishers, 2022
DOI: 10.6084/m9.figshare.21582873.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Baseline_Clinical_Characteristics_and_Complement_Biomarkers_of_Patients_with_C3_Glomerulopathy_Enrolled_in_Two_Phase_2_Studies_Investigating_the_Factor_D_Inhibitor_Danicopan/21582873/1
Dataset

Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan

Datasets

Search results

Supplementary Material for: Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan